Live birth rates after MESA or TESE in men with obstructive azoospermia: is there a difference?
OBJECTIVE
How do live birth rates compare after intracytoplasmic sperm injection (ICSI) for men with obstructive azoospermia when using sperm derived from testicular sperm extraction (TESE) versus microsurgical epididymal sperm aspiration (MESA)?


CONCLUSIONS
Our study suggests that proximal epididymal sperm (from MESA) result in higher live birth rates as compared with testicular sperm (from TESE) in couples where the man has obstructive azoospermia due to congenital bilateral absence of the vas deferens (CBAVD) or vasectomy.


BACKGROUND
For couples with obstructive azoospermia, MESA (epididymal sperm) and TESE (testicular sperm) have generally been assumed to be equivalent for use in ICSI. But this assumption has never been confirmed, and this view has important clinical and basic scientific consequences.


METHODS
This was a retrospective study of a consecutive cohort of 374 men with obstructive azoospermia and normal spermatogenesis, who underwent IVF and ICSI using either epididymal sperm or testicular sperm in the period 2000-2009.


METHODS
The study included men undergoing MESA or TESE at St. Luke's Hospital for obstructive azoospermia due to CBAVD or vasectomy.


RESULTS
A total of 280 couples underwent MESA and 94 underwent TESE with ICSI. The live birth rate was 39% after MESA-ICSI and 24% after TESE-ICSI. The MESA-ICSI cycles also resulted in a significantly higher implantation rate and significantly higher clinical and ongoing pregnancy rates than the TESE-ICSI cycles. There was no significant difference in results between fresh or frozen sperm for both MESA and TESE. When adjusted for the available confounders, the odds ratio for live birth was significantly in favour of MESA-ICSI versus TESE-ICSI (OR 1.82; 95% CI 1.05-3.67). The only significant confounders were female age and ovarian reserve.


CONCLUSIONS
This is a retrospective cohort study and not a randomized clinical trial.


CONCLUSIONS
Our study suggests that some aspect of sperm maturation after the sperm leaves the testicle to enter the epididymis is required for the most optimal results, even when ICSI is used for fertilization.


BACKGROUND
No funding was used and there are no competing interests.
Center for Reproductive Medicine, Women's and Children's Hospital, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.
Madelon
M
van Wely
Infertility Center of St. Louis, St. Luke's Hospital, St. Louis, MO 63017, USA.
Natalie
N
Barbey
Center for Reproductive Medicine, Women's and Children's Hospital, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.
Andreas
A
Meissner
Center for Reproductive Medicine, Women's and Children's Hospital, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.
Sjoerd
S
Repping
Center for Reproductive Medicine, Women's and Children's Hospital, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands Infertility Center of St. Louis, St. Luke's Hospital, St. Louis, MO 63017, USA silber@infertile.com.
Sherman J
SJ
Silber
D000328:Adult; D053713:Azoospermia / Q000628:therapy*; D001723:Birth Rate; D004822:Epididymis / Q000601:surgery*; D005260:Female; D006801:Humans; D007248:Infertility, Male; D008297:Male; D008853:Microscopy; D011247:Pregnancy; D018873:Pregnancy Rate; D012189:Retrospective Studies; D020554:Sperm Injections, Intracytoplasmic; D053625:Sperm Retrieval; D013094:Spermatozoa / Q000473:pathology; D013737:Testis / Q000033:anatomy & histology / Q000601:surgery; D014649:Vas Deferens / Q000002:abnormalities; D014669:Vasovasostomy
MESA; TESE; assisted reproduction; infertility; obstructive azoospermia